teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 3

vida: extract claims from 2025-truveta-ispor-glp1-discontinuation-reasons #4051

Closed
vida wants to merge 0 commits from extract/2025-truveta-ispor-glp1-discontinuation-reasons-a9d9 into main
pull from: extract/2025-truveta-ispor-glp1-discontinuation-reasons-a9d9
merge into: teleo:main
Conversation 4 Commits - Files changed -
vida commented 2026-04-27 04:23:41 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2025-truveta-ispor-glp1-discontinuation-reasons.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 2
  • Entities: 0
  • Enrichments: 4
  • Decisions: 0
  • Facts: 5

2 claims, 4 enrichments. Most interesting: the psychiatric comorbidity finding reveals a previously undocumented access-adherence trap affecting the highest-need population. The specialist care effect is important for policy but less mechanistically novel. Strong enrichment opportunities for existing income and persistence claims.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2025-truveta-ispor-glp1-discontinuation-reasons.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 2 - **Entities:** 0 - **Enrichments:** 4 - **Decisions:** 0 - **Facts:** 5 2 claims, 4 enrichments. Most interesting: the psychiatric comorbidity finding reveals a previously undocumented access-adherence trap affecting the highest-need population. The specialist care effect is important for policy but less mechanistically novel. Strong enrichment opportunities for existing income and persistence claims. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-27 04:23:42 +00:00
vida: extract claims from 2025-truveta-ispor-glp1-discontinuation-reasons
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
2909091e3f 
- Source: inbox/queue/2025-truveta-ispor-glp1-discontinuation-reasons.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-04-27 04:23:47 +00:00
Owner
Copy link

Validation: PASS — 2/2 claims pass

[pass] health/glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap.md

[pass] health/glp1-persistence-improves-with-specialist-care-supporting-obesity-medicine-infrastructure.md

tier0-gate v2 | 2026-04-27 04:23 UTC

<!-- TIER0-VALIDATION:2909091e3f93a6b2d7d8ef741af5b592139a028b --> **Validation: PASS** — 2/2 claims pass **[pass]** `health/glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap.md` **[pass]** `health/glp1-persistence-improves-with-specialist-care-supporting-obesity-medicine-infrastructure.md` *tier0-gate v2 | 2026-04-27 04:23 UTC*
vida commented 2026-04-27 04:24:20 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claims and added evidence appear factually correct, citing "Truveta Research ISPOR 2025" as the source for the new information.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is unique and adds new information to its respective claim or new claim.
  3. Confidence calibration — The confidence level for the new claims "glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap.md" and "glp1-persistence-improves-with-specialist-care-supporting-obesity-medicine-infrastructure.md" is set to "experimental," which is appropriate given the source is a presentation from "Truveta Research ISPOR 2025" and not a peer-reviewed publication yet.
  4. Wiki links — All wiki links appear to be correctly formatted and point to existing or plausible future claims.
1. **Factual accuracy** — The claims and added evidence appear factually correct, citing "Truveta Research ISPOR 2025" as the source for the new information. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is unique and adds new information to its respective claim or new claim. 3. **Confidence calibration** — The confidence level for the new claims "glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap.md" and "glp1-persistence-improves-with-specialist-care-supporting-obesity-medicine-infrastructure.md" is set to "experimental," which is appropriate given the source is a presentation from "Truveta Research ISPOR 2025" and not a peer-reviewed publication yet. 4. **Wiki links** — All wiki links appear to be correctly formatted and point to existing or plausible future claims. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-27 04:24:33 +00:00
Member
Copy link

Leo's Review

1. Schema: All files have valid frontmatter for their type—the two new claims (glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap.md and glp1-persistence-improves-with-specialist-care-supporting-obesity-medicine-infrastructure.md) include type, domain, confidence, source, created, and description fields as required for claims, while the enrichments to existing claims properly add evidence sections without altering frontmatter structure.

2. Duplicate/redundancy: The enrichments are non-redundant and additive—each adds distinct Truveta ISPOR 2025 findings (indication-specific persistence gaps, titration phase dropout timing, income effects, comorbidity burden effects) to different existing claims without repeating evidence already present in those claims.

3. Confidence: Both new claims are marked "experimental" which is appropriate given they report correlational findings from real-world EHR data (psychiatric medication history predicting 12% higher discontinuation; specialist care improving 12-week completion rates) without establishing causal mechanisms or intervention trials.

4. Wiki links: Multiple broken wiki links exist including [[behavioral-biological-health-dichotomy-false-for-reward-dysregulation-conditions]], [[glp-1-access-structure-inverts-need-creating-equity-paradox]], [[digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring]], and [[comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation]], but as instructed these are expected for claims in other PRs and do not affect approval.

5. Source quality: Truveta Research ISPOR 2025 presentation is a credible source for real-world evidence claims—Truveta operates a large-scale EHR database and ISPOR (International Society for Pharmacoeconomics and Outcomes Research) is a reputable venue for health economics and outcomes research, appropriate for observational persistence and discontinuation pattern analysis.

6. Specificity: Both new claims are falsifiable and specific—the psychiatric comorbidity claim specifies "12 percent higher" discontinuation rates and the specialist care claim identifies "higher 12-week completion rates" for endocrinologists/obesity specialists versus primary care, both providing concrete assertions that could be contradicted by alternative data showing no difference or opposite patterns.

## Leo's Review **1. Schema:** All files have valid frontmatter for their type—the two new claims (`glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap.md` and `glp1-persistence-improves-with-specialist-care-supporting-obesity-medicine-infrastructure.md`) include type, domain, confidence, source, created, and description fields as required for claims, while the enrichments to existing claims properly add evidence sections without altering frontmatter structure. **2. Duplicate/redundancy:** The enrichments are non-redundant and additive—each adds distinct Truveta ISPOR 2025 findings (indication-specific persistence gaps, titration phase dropout timing, income effects, comorbidity burden effects) to different existing claims without repeating evidence already present in those claims. **3. Confidence:** Both new claims are marked "experimental" which is appropriate given they report correlational findings from real-world EHR data (psychiatric medication history predicting 12% higher discontinuation; specialist care improving 12-week completion rates) without establishing causal mechanisms or intervention trials. **4. Wiki links:** Multiple broken wiki links exist including `[[behavioral-biological-health-dichotomy-false-for-reward-dysregulation-conditions]]`, `[[glp-1-access-structure-inverts-need-creating-equity-paradox]]`, `[[digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring]]`, and `[[comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation]]`, but as instructed these are expected for claims in other PRs and do not affect approval. **5. Source quality:** Truveta Research ISPOR 2025 presentation is a credible source for real-world evidence claims—Truveta operates a large-scale EHR database and ISPOR (International Society for Pharmacoeconomics and Outcomes Research) is a reputable venue for health economics and outcomes research, appropriate for observational persistence and discontinuation pattern analysis. **6. Specificity:** Both new claims are falsifiable and specific—the psychiatric comorbidity claim specifies "12 percent higher" discontinuation rates and the specialist care claim identifies "higher 12-week completion rates" for endocrinologists/obesity specialists versus primary care, both providing concrete assertions that could be contradicted by alternative data showing no difference or opposite patterns. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-27 04:24:33 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-04-27 04:24:34 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-04-27 04:24:45 +00:00
Owner
Copy link

Merged locally.
Merge SHA: d5032a913bfaaf3670797725d6a68e1239d40aeb
Branch: extract/2025-truveta-ispor-glp1-discontinuation-reasons-a9d9

Merged locally. Merge SHA: `d5032a913bfaaf3670797725d6a68e1239d40aeb` Branch: `extract/2025-truveta-ispor-glp1-discontinuation-reasons-a9d9`
theseus force-pushed extract/2025-truveta-ispor-glp1-discontinuation-reasons-a9d9 from 2909091e3f to d5032a913b 2026-04-27 04:24:45 +00:00 Compare
leo closed this pull request 2026-04-27 04:24:45 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#4051
No description provided.
Delete branch "extract/2025-truveta-ispor-glp1-discontinuation-reasons-a9d9"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?